Total Payments
$3,098
2024 Payments
$79.47
Companies
29
Transactions
202
Medicare Patients
502
Medicare Billing
$50,647
Payment Breakdown by Category
Food & Beverage$3,098 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,098 | 202 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $938.70 | 54 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $335.59 | 25 | $0 (2021) |
| Novo Nordisk Inc | $308.91 | 22 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $242.54 | 13 | $0 (2023) |
| Lilly USA, LLC | $195.94 | 13 | $0 (2022) |
| Allergan Inc. | $143.73 | 13 | $0 (2018) |
| Amarin Pharma Inc. | $127.47 | 8 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $118.67 | 7 | $0 (2022) |
| Takeda Pharmaceuticals America, Inc. | $68.39 | 8 | $0 (2017) |
| ABBVIE INC. | $61.83 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $79.47 | 4 | ABBVIE INC. ($41.21) |
| 2023 | $58.89 | 3 | SANOFI-AVENTIS U.S. LLC ($38.27) |
| 2022 | $278.36 | 16 | SANOFI-AVENTIS U.S. LLC ($97.94) |
| 2021 | $484.19 | 33 | Novo Nordisk Inc ($166.11) |
| 2020 | $271.82 | 17 | AstraZeneca Pharmaceuticals LP ($125.77) |
| 2019 | $517.29 | 28 | AstraZeneca Pharmaceuticals LP ($241.27) |
| 2018 | $343.78 | 25 | AstraZeneca Pharmaceuticals LP ($130.77) |
| 2017 | $1,064 | 76 | AstraZeneca Pharmaceuticals LP ($358.09) |
All Payment Transactions
202 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/02/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.90 | General |
| 04/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: NEUROSCIENCE | ||||||
| 01/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.36 | General |
| 10/10/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2023 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/09/2023 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/12/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Diabetes | ||||||
| 08/22/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/02/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Diabetes | ||||||
| 06/14/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/17/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/06/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological), TOUJEO | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/03/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: DIABETES | ||||||
| 04/14/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Neuroscience | ||||||
| 03/30/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Diabetes | ||||||
| 03/08/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/03/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Diabetes | ||||||
| 03/02/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Diabetes | ||||||
| 02/22/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/10/2022 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Diabetes | ||||||
| 02/04/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/01/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/30/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Diabetes | ||||||
| 11/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: PRIMARY CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 119 | 154 | $23,646 | $11,220 |
| 2022 | 4 | 119 | 178 | $29,503 | $12,532 |
| 2021 | 4 | 146 | 244 | $40,302 | $17,297 |
| 2020 | 4 | 118 | 202 | $30,847 | $9,598 |
Total Patients
502
Total Services
778
Medicare Billing
$50,647
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 69 | $13,800 | $5,669 | 41.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 35 | 35 | $7,000 | $4,435 | 63.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 38 | 38 | $950.00 | $690.84 | 72.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 12 | $1,896 | $425.88 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 87 | $17,400 | $6,832 | 39.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 25 | 25 | $5,000 | $3,258 | 65.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 41 | $6,478 | $1,981 | 30.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 25 | 25 | $625.00 | $461.48 | 73.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 122 | $24,400 | $10,369 | 42.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 69 | $10,902 | $3,528 | 32.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 21 | 21 | $4,200 | $2,797 | 66.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 32 | 32 | $800.00 | $602.18 | 75.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 111 | $22,200 | $7,033 | 31.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 49 | $7,742 | $2,233 | 28.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 13 | 13 | $325.00 | $236.82 | 72.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 18 | 29 | $580.00 | $94.35 | 16.3% |
About Dr. Angel Gomez, M.D
Dr. Angel Gomez, M.D is a Internal Medicine healthcare provider based in Elgin, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1730236035.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Angel Gomez, M.D has received a total of $3,098 in payments from pharmaceutical and medical device companies, with $79.47 received in 2024. These payments were reported across 202 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,098).
As a Medicare-enrolled provider, Gomez has provided services to 502 Medicare beneficiaries, totaling 778 services with total Medicare billing of $50,647. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Elgin, IL
- Active Since 01/05/2007
- Last Updated 08/22/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1730236035
Products in Payments
- FARXIGA (Drug) $539.57
- JANUVIA (Drug) $269.61
- SYMBICORT (Drug) $236.31
- Ozempic (Drug) $194.66
- TRULICITY (Drug) $141.75
- JARDIANCE (Drug) $133.17
- Vascepa (Drug) $127.47
- SOLIQUA 100/33 (Biological) $117.44
- LINZESS (Drug) $72.56
- BEVESPI AEROSPHERE (Drug) $69.47
- Tresiba (Drug) $65.87
- UBRELVY (Drug) $61.83
- Amitiza (Drug) $61.50
- ENTRESTO (Drug) $42.68
- TOUJEO (Biological) $37.81
- Nesina (Drug) $37.13
- ADVAIR (Drug) $36.73
- Aimovig (Biological) $36.20
- TOUJEO (Drug) $35.44
- VIBERZI (Drug) $35.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Elgin
Mr. Michael Hernandez, M.d, M.D
Internal Medicine — Payments: $26,674
Internal Medicine $26,674
Dr. Robert Tiballi, D.o, D.O
Internal Medicine — Payments: $20,485
Internal Medicine $20,485
Paula Belmar, Md, MD
Internal Medicine — Payments: $12,301
Internal Medicine $12,301
Dr. Heena Shyamani, M.d, M.D
Internal Medicine — Payments: $12,014
Internal Medicine $12,014
Mr. Richard Baley, M.d, M.D
Internal Medicine — Payments: $11,178
Internal Medicine $11,178
John Adams, Md, MD
Internal Medicine — Payments: $10,883
Internal Medicine $10,883